R1 RCM Inc.
RCM
Rangering i aksjer
#3055
R1 RCM Inc. leverages technology to provide solutions that both optimize the... R1 RCM Inc. leverages technology to provide solutions that both optimize the patient experience and bolster the financial performance of hospitals, health systems, and medical groups. Its core offering is comprehensive revenue cycle management (RCM), meticulously designed to address the entire spectrum of financial complexities faced by healthcare providers. Beyond this holistic approach, R1 RCM also delivers flexible, specialized solutions. These encompass physician advisory services, guiding healthcare organizations on compliant classification of hospital visits (in-patient versus out-patient observation) for billing purposes. Additional modular services include: Practice management: Offering administrative and operational support to streamline patient care, alongside outsourcing of non-essential functions. Revenue integrity: Encompassing critical elements like accurate charge capture, meticulous maintenance of the charge description master, and strategic pricing services. Coding management: Featuring business intelligence and analytical insights, human capital management, robust accountability frameworks, and quality assurance programs. Patient experience enhancements. Business office support. Furthermore, the company provides cloud-based (SaaS) platforms for scheduling and improving patient access. R1 RCM Inc. was established in 2003 and is headquartered in Murray, Utah.
Aksjekurs
$14.31
Sist synkronisert: 2024-11-20
Markedsverdi
$5.97B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel R1 RCM Inc. (RCM)
Kategori
Healthcare
P/E-forhold for R1 RCM Inc. (RCM)
P/E-forhold per October 2026 TTM: 1.81K
Ifølge R1 RCM Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 1.81K. Ved slutten av 2022 hadde selskapet en P/E på -66.98.
P/E-forholdshistorikk for R1 RCM Inc. fra 2007 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 1.81K | 35.10% |
| 2023 | 1.34K | -2,101.69% |
| 2022 | -66.98 | -186.18% |
| 2021 | 77.72 | 222.09% |
| 2020 | 24.13 | -79.99% |
| 2019 | 120.61 | -740.30% |
| 2018 | -18.84 | 145.12% |
| 2017 | -7.68 | -603.16% |
| 2016 | 1.53 | -149.23% |
| 2015 | -3.10 | -4.47% |
| 2014 | -3.25 | -263.51% |
| 2013 | 1.99 | -189.33% |
| 2012 | -2.22 | -124.77% |
| 2011 | 8.98 | -40.69% |
| 2010 | 15.14 | 122.70% |
| 2009 | 6.80 | -91.53% |
| 2008 | 80.25 | -37.73% |
| 2007 | 128.87 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 19.68 | -98.91% |
US
|
|
| 64.40 | -96.44% |
AU
|
|
| 44.30 | -97.55% |
US
|
|
| -47.78 | -102.64% |
US
|
|
| -123.90 | -106.84% |
US
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.